{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:27:06Z","timestamp":1789954026479,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004588","name":"Istituto Pasteur-Fondazione Cenci Bolognetti","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.antiviral.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T04:06:56Z","timestamp":1347682016000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt\u2019s lymphoma cells by affecting multiple molecular targets"],"prefix":"10.1016","volume":"96","author":[{"given":"Alessandra","family":"De Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Lacanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Colavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.09.003_b0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","article-title":"Reactivation of Epstein-Barr virus from latency","volume":"15","author":"Amon","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0010","first-page":"129","article-title":"The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation","volume":"1072","author":"Angel","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.antiviral.2012.09.003_b0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1756-9966-28-96","article-title":"Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use","volume":"28","author":"Berardi","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/152308601317203567","article-title":"Biological effects of resveratrol","volume":"3","author":"Bhat","year":"2001","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.antiviral.2012.09.003_b0025","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.antiviral.2012.09.003_b0030","doi-asserted-by":"crossref","DOI":"10.1042\/BST0380050","article-title":"Antiviral activity of resveratrol","author":"Campagna","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.antiviral.2012.09.003_b0035","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1128\/jvi.69.7.4206-4212.1995","article-title":"Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1","volume":"69","author":"Cayrol","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0040","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1541-7786.MCR-11-0145","article-title":"Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt\u2019s lymphoma cells depending on viral latency program","volume":"9","author":"De Leo","year":"2011","journal-title":"Molecular cancer research: MCR"},{"key":"10.1016\/j.antiviral.2012.09.003_b0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/13543771003796590","article-title":"Epstein-Barr virus: novel patented therapeutics","volume":"20","author":"De Paoli","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.antiviral.2012.09.003_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2005.06.008","article-title":"Effect of resveratrol on herpes simplex virus vaginal infection in the mouse","volume":"67","author":"Docherty","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.antiviral.2006.07.004","article-title":"Resveratrol inhibition of varicella-zoster virus replication in vitro","volume":"72","author":"Docherty","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0060","doi-asserted-by":"crossref","first-page":"e33364","DOI":"10.1371\/journal.pone.0033364","article-title":"Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1","volume":"7","author":"Dyson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.003_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2004.03.002","article-title":"3,4\u2032,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling","volume":"63","author":"Evers","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2006.06.011","article-title":"Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells","volume":"72","author":"Faith","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0075","first-page":"333","article-title":"Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis","volume":"32","author":"Gaeta","year":"2009","journal-title":"New Microbiol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0080","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s12011-011-9135-5","article-title":"Reactive oxygen species production and antioxidant enzyme expression after Epstein-Barr virus lytic cycle induction in Raji cell line","volume":"144","author":"Gargouri","year":"2011","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0085","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM198512193132502","article-title":"Replication of Epstein-Barr virus within the epithelial cells of oral \u201chairy\u201d leukoplakia, an AIDS-associated lesion","volume":"313","author":"Greenspan","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.antiviral.2012.09.003_b0090","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0095","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/JVI.02301-07","article-title":"Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells","volume":"82","author":"Hsu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/ijc.22839","article-title":"Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease","volume":"121","author":"Jones","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.antiviral.2012.09.003_b0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.bcp.2006.08.005","article-title":"Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets","volume":"72","author":"Kundu","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","article-title":"Spectrum of Epstein-Barr virus-associated diseases","volume":"1","author":"Kutok","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12011-009-8555-y","article-title":"Transcription of the Epstein-Barr virus lytic cycle activator BZLF-1 during oxidative stress induction","volume":"137","author":"Lassoued","year":"2010","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.antiviral.2012.09.003_b0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1044-579X(02)00128-1","article-title":"NF-kappaB in cancer: a marked target","volume":"13","author":"Lin","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1099\/vir.0.18845-0","article-title":"A novel function for the Epstein\u2013Barr virus transcription factor EB1\/Zta: induction of transcription of the hIL-10 gene","volume":"84","author":"Mahot","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0135","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.4049\/jimmunol.164.12.6509","article-title":"Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation","volume":"164","author":"Manna","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0140","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.4049\/jimmunol.145.6.1859","article-title":"Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis","volume":"145","author":"Martin","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-8-18","article-title":"Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds","volume":"8","author":"Matusali","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.antiviral.2012.09.003_b0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.178.2.439","article-title":"Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus","volume":"178","author":"Miyazaki","year":"1993","journal-title":"J Exper Med"},{"key":"10.1016\/j.antiviral.2012.09.003_b0155","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1086\/429694","article-title":"Inhibition of influenza A virus replication by resveratrol","volume":"191","author":"Palamara","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.antiviral.2012.09.003_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2741\/s6","article-title":"Nuclear factor-kappa B links carcinogenic and chemopreventive agents","volume":"1","author":"Ralhan","year":"2009","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.antiviral.2012.09.003_b0165","series-title":"Epstein Barr Virus","author":"Rickinson","year":"2007"},{"key":"10.1016\/j.antiviral.2012.09.003_b0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BJ20050791","article-title":"Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells","volume":"393","author":"Saatian","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.antiviral.2012.09.003_b0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10555-010-9239-y","article-title":"Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis","volume":"29","author":"Shu","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.antiviral.2012.09.003_b0180","doi-asserted-by":"crossref","first-page":"e29513","DOI":"10.1371\/journal.pone.0029513","article-title":"Resveratrol Inhibits Protein Translation in Hepatic Cells","volume":"6","author":"Villa-Cuesta","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.09.003_b0185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2174\/138955710792007150","article-title":"New strategies and patent therapeutics in EBV-associated diseases","volume":"10","author":"Villegas","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.antiviral.2012.09.003_b0190","doi-asserted-by":"crossref","DOI":"10.1080\/01635581.2012.667862","article-title":"The anticancer effects of Resveratrol: modulation of transcription factors","author":"Whitlock","year":"2012","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.antiviral.2012.09.003_b0195","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JVI.78.9.4847-4865.2004","volume":"78","author":"Wu","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.antiviral.2012.09.003_b0200","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.3390\/molecules15107115","article-title":"Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle","volume":"15","author":"Yiu","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2012.09.003_b0205","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jcb.23431","article-title":"Cellular and molecular effects of resveratrol in health and disease","volume":"113","author":"Yu","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.antiviral.2012.09.003_b0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/j.1460-2075.1993.tb05646.x","article-title":"Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus","volume":"12","author":"Zabel","year":"1993","journal-title":"Embo J"},{"key":"10.1016\/j.antiviral.2012.09.003_b0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.lfs.2009.07.014","article-title":"Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD+-dependent SIRT1 activity","volume":"85","author":"Zhang","year":"2009","journal-title":"Life Sci"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:25:43Z","timestamp":1759062343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0166354212002008"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.09.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt\u2019s lymphoma cells by affecting multiple molecular targets","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}